Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department

NCT05691218 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT05691218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05691218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department
Lead sponsor
Poitiers University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 19, 2024
Completion date
March 19, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate asthma exacerbation, severe asthma exacerbation